Neosalvarsan is a synthetic chemotherapeutic that is an organoarsenic compound. It became available in 1912 and superseded the more toxic and less water-soluble...

developed a more soluble (but slightly less effective) arsenical compound, Neosalvarsan (neoarsphenamine), which was easier to prepare, and it became available...

Progressively, with the discovery of organic arsenicals such as Salvarsan and Neosalvarsan (1910s), the development of pyrotherapy (1920s), and the widespread availability...

the antibiotics themselves. 1911 – Arsphenamine, also Salvarsan 1912 – Neosalvarsan 1935 – Prontosil (an oral precursor to sulfanilamide), the first sulfonamide...

Organoarsenic compounds, such as feed additives (roxarsone) and medication (neosalvarsan), are derived from arsenic trioxide.[citation needed] Industrial uses...

improvement as to side effects and solubility and was replaced in 1911 with Neosalvarsan. Ehrlich's work illuminated the existence of the blood-brain barrier...

was commercially introduced in 1910, and in 1913, a less toxic form, "Neosalvarsan" (Compound 914), was released in the market. These drugs became the principal...

Yaws before and after treatment with neosalvarsan, an obsolete treatment...

treating diseases such as cancer or psoriasis. Arsphenamine, as well as neosalvarsan, was indicated for syphilis, but has been superseded by modern antibiotics...

later discovered the related organo-arsenical, Neosalvarsan. The side-effect profile of Neosalvarsan is gentler and its storage and preparation were...